A Phase 1b/2 Study of Entospletinib (GS-9973) Monotherapy and in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
September 16, 2019
Administered By
Duke Cancer Institute
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
September 16, 2019